HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jon Erlendsson Selected Research

Inflammation (Inflammations)

12/2011Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
8/2011ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
6/2010Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jon Erlendsson Research Topics

Disease

3Inflammation (Inflammations)
12/2011 - 06/2010
2Necrosis
08/2011 - 06/2010
2Ankylosing Spondylitis
08/2011 - 10/2004
1Spondylarthritis (Spinal Arthritis)
12/2011
1Axial Spondyloarthritis
08/2011
1Wounds and Injuries (Trauma)
10/2004

Drug/Important Bio-Agent (IBA)

3C-Reactive ProteinIBA
12/2011 - 06/2010
2Cartilage Oligomeric Matrix ProteinIBA
12/2011 - 08/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2011 - 06/2010
2Biomarkers (Surrogate Marker)IBA
12/2011 - 08/2011
2OsteocalcinIBA
12/2011 - 08/2011
2Interleukin-6 (Interleukin 6)IBA
12/2011 - 08/2011
2Matrix Metalloproteinase 3 (Stromelysin 1)IBA
12/2011 - 08/2011
2Matrix Metalloproteinases (MMPs)IBA
12/2011 - 08/2011
2Collagen Type II (Type II Collagen)IBA
12/2011 - 08/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2011 - 08/2011
2Aggrecans (Aggrecan)IBA
12/2011 - 08/2011
1Collagen Type I (Type I Collagen)IBA
08/2011
1Adalimumab (Humira)FDA Link
06/2010
1Infliximab (Remicade)FDA Link
06/2010
1Etanercept (Enbrel)FDA Link
06/2010
1HLA-B27 Antigen (HLA B27 Antigen)IBA
10/2004

Therapy/Procedure

3Therapeutics
12/2011 - 10/2004